Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bähring, Sylvia Dr. (1) Birchmeier, Walter Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Gotthardt, Michael Prof. Dr. (1) Hübner, Norbert Prof. Dr. (18) Hummel, Oliver (1) Janz, Martin Dr. (6) Kammertöns, Thomas Dr. (3) Kirchner, Marieluise Dr. (2) Klaassen, Sabine Prof. Dr. med. (1) Klaus-Bergmann, Alexandra Dr. (1) Landthaler, Markus Prof. Dr. (1) Langanki, Reika (1) Lee, Young-Ae Prof. Dr. (3) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lewin, Gary Prof. Dr. (1) Luft, Friedrich Prof. Dr. (1) Lusatis, Simone (1) Maatz, Henrike Dr. (2) Marenholz, Ingo Dr. (2) Mathas, Stephan Dr. (5) Müller, Marion (1) Perrot, Andreas (1) Pombo, Ana Prof. Dr. (1) Radke, Michael Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Saar, Kathrin Dr. (7) Schmidt-Krüger, Vanessa Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (6) Uckert, Wolfgang Prof. Dr. (1) Walther, Wolfgang Prof. Dr. (1) Willnow, Thomas Prof. Dr. (1) Wyler, Emanuel Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (11) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (2) (-) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Immunologie und Gentherapie (11) Tumorgenetik und zelluläre Stressantworten (1) (-) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) (-) 2012 (6) 2014 (4) 2015 (4) 2016 (4) 2017 (6) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 13 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeGenetik und Genomik von Herz- KreislauferkrankungenMolekulare Immunologie und Gentherapie 199220062012 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. November 1992 / J Immunol Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity S. Ehlers M.E. Mielke T. Blankenstein H. Hahn 01. Januar 1992 / Immunology Abnormal TNF production in prediabetic BB rats is linked to defective CD45R expression H. Rothe I. Schuller G. Richter C.V. Jongeneel U. Kiesel T. Diamantstein T. Blankenstein H. Kolb 01. Januar 1992 / Eur J Immunol Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction C. Platzer G. Richter K. Ueberla W. Mueller H. Bloecker T. Diamantstein T. Blankenstein 01. Januar 1992 / Eur J Immunol Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma C. Platzer G. Richter K. Ueberla H. Hock T. Diamantstein T. Blankenstein 01. November 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein 01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens 01. April 2012 / Nat Rev Cancer The determinants of tumour immunogenicity T. Blankenstein P.G. Coulie E. Gilboa E.M. Jaffee Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. November 1992 / J Immunol Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity S. Ehlers M.E. Mielke T. Blankenstein H. Hahn
01. Januar 1992 / Immunology Abnormal TNF production in prediabetic BB rats is linked to defective CD45R expression H. Rothe I. Schuller G. Richter C.V. Jongeneel U. Kiesel T. Diamantstein T. Blankenstein H. Kolb
01. Januar 1992 / Eur J Immunol Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction C. Platzer G. Richter K. Ueberla W. Mueller H. Bloecker T. Diamantstein T. Blankenstein
01. Januar 1992 / Eur J Immunol Interleukin-4-mediated tumor suppression in nude mice involves interferon-gamma C. Platzer G. Richter K. Ueberla H. Hock T. Diamantstein T. Blankenstein
01. November 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein
01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens
01. April 2012 / Nat Rev Cancer The determinants of tumour immunogenicity T. Blankenstein P.G. Coulie E. Gilboa E.M. Jaffee